Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M95,779Revenue (TTM) $M31,576Net Margin (%)47.8Altman Z-Score3.8
Enterprise Value $M110,526EPS (TTM) $10.8Operating Margin %60.8Piotroski F-Score5
P/E(ttm)6.7Beneish M-Score-2.8Pre-tax Margin (%)59.0Higher ROA y-yN
Price/Book5.710-y EBITDA Growth Rate %--Quick Ratio1.8Cash flow > EarningsY
Price/Sales3.35-y EBITDA Growth Rate %45.9Current Ratio1.9Lower Leverage y-yY
Price/Free Cash Flow5.9y-y EBITDA Growth Rate %3.4ROA % (ttm)29.4Higher Current Ratio y-yN
Dividend Yield %2.5PEG0.2ROE % (ttm)92.2Less Shares Outstanding y-yY
Payout Ratio %17.0Shares Outstanding M1,317ROIC % (ttm)55.1Gross Margin Increase y-yN

Gurus Latest Trades with GILD

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GILDJohn Rogers 2016-09-30 Add0.09%$76.89 - $88.55
($81.23)
$ 72.70-11%Add 6.18%1,532,528
GILDJoel Greenblatt 2016-09-30 Reduce-0.09%$76.89 - $88.55
($81.23)
$ 72.70-11%Reduce -9.11%923,534
GILDRonald Muhlenkamp 2016-09-30 Reduce-0.08%$76.89 - $88.55
($81.23)
$ 72.70-11%Reduce -1.15%214,495
GILDDavid Dreman 2016-09-30 Reduce-0.04%$76.89 - $88.55
($81.23)
$ 72.70-11%Reduce -3.06%21,855
GILDNWQ Managers 2016-09-30 Reduce-0.04%$76.89 - $88.55
($81.23)
$ 72.70-11%Reduce -24.38%81,896
GILDT Rowe Price Equity Income Fund 2016-09-30 Add0.02%$76.89 - $88.55
($81.23)
$ 72.70-11%Add 3.64%1,425,000
GILDFirst Eagle Investment 2016-09-30 Add0.01%$76.89 - $88.55
($81.23)
$ 72.70-11%Add 220.65%49,700
GILDMario Gabelli 2016-09-30 Reduce-0.01%$76.89 - $88.55
($81.23)
$ 72.70-11%Reduce -65.34%12,414
GILDKen Fisher 2016-09-30 Reduce$76.89 - $88.55
($81.23)
$ 72.70-11%Reduce -0.44%444,529
GILDLeon Cooperman 2016-06-30 Sold Out -1.26%$78.25 - $102.29
($88.79)
$ 72.70-18%Sold Out0
GILDJohn Rogers 2016-06-30 Add0.09%$78.25 - $102.29
($88.79)
$ 72.70-18%Add 6.09%1,443,305
GILDJoel Greenblatt 2016-06-30 Add0.05%$78.25 - $102.29
($88.79)
$ 72.70-18%Add 5.01%1,016,142
GILDRonald Muhlenkamp 2016-06-30 Reduce-0.04%$78.25 - $102.29
($88.79)
$ 72.70-18%Reduce -0.45%217,000
GILDT Rowe Price Equity Income Fund 2016-06-30 Add0.01%$78.25 - $102.29
($88.79)
$ 72.70-18%Add 1.58%1,375,000
GILDKen Fisher 2016-06-30 Reduce-0.01%$78.25 - $102.29
($88.79)
$ 72.70-18%Reduce -8.32%446,493
GILDNWQ Managers 2016-06-30 Reduce-0.01%$78.25 - $102.29
($88.79)
$ 72.70-18%Reduce -6.64%108,300
GILDDavid Dreman 2016-06-30 Reduce-0.01%$78.25 - $102.29
($88.79)
$ 72.70-18%Reduce -2.86%22,546
GILDGeorge Soros 2016-06-30 Sold Out -0.01%$78.25 - $102.29
($88.79)
$ 72.70-18%Sold Out0
GILDFirst Eagle Investment 2016-06-30 Add$78.25 - $102.29
($88.79)
$ 72.70-18%Add 68.48%15,500
GILDMario Gabelli 2016-06-30 Reduce$78.25 - $102.29
($88.79)
$ 72.70-18%Reduce -11.97%35,819
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GILD is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


GILD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MARTIN JOHN CExecutive Chairman 2016-12-01Sell100,000$73.33-0.86view
MADIGAN JOHN WDirector 2016-11-18Sell105,000$74.86-2.89view
Alton Gregg HEVP Comm&Acs ALA, Corp&Med Aff 2016-11-09Sell10,000$79-7.97view
MARTIN JOHN CExecutive Chairman 2016-11-01Sell100,000$73.76-1.44view
MARTIN JOHN CExecutive Chairman 2016-10-03Sell100,000$77.63-6.35view
Alton Gregg HEVP Comm&Acs ALA, Corp&Med Aff 2016-09-22Sell5,000$81.84-11.17view
MILLIGAN JOHN FPresident and CEO 2016-09-06Sell70,000$77.74-6.48view
MARTIN JOHN CExecutive Chairman 2016-09-01Sell100,000$77.48-6.17view
Lofton Kevin EDirector 2016-08-24Sell3,500$81.97-11.31view
MILLIGAN JOHN FPresident and CEO 2016-08-01Sell70,000$70.942.48view

Quarterly/Annual Reports about GILD:

News about GILD:

Articles On GuruFocus.com
5 Companies for Enterprising Investors Near 52-Week Lows Dec 05 2016 
10 Low P/E Picks for the Enterprising Investor Dec 05 2016 
17 Questions With Gaspare Civiero of the Value Investor Nov 30 2016 
Gilead Is a Strong Contrarian 'Buy' Nov 29 2016 
23 Questions With Gabriele Grego Nov 28 2016 
Gurus Invest in Undervalued Biotech Stocks Nov 25 2016 
Gilead Sciences: Dirt Cheap With Lots of Growth Potential Nov 17 2016 
Gilead Sciences’ Miracle Drug Combination Nov 15 2016 
3 Health Industry Sectors Bound to Profit From a Trump Presidency Nov 11 2016 
6 Undervalued Stocks Trading Below the Peter Lynch Value Oct 26 2016 

More From Other Websites
Ariel CIO: Health Care Stocks Left Behind in Rally Dec 09 2016
Top Research Reports for NVIDIA, Medtronic & Gilead Sciences Dec 09 2016
Gilead Files New Drug Application for Hep C Combo Dec 09 2016
Lululemon and Tailored Brands surge; Gilead and Grumman drop Dec 08 2016
Health care sector suffers: Time to buy the dip? Dec 08 2016
FitBit, Gilead Sciences in Thursday’s 52-Week Low Club Dec 08 2016
Gilead Sciences: We Can Get Past This… Dec 08 2016
8:13 am Gilead Sciences submits new drug application to FDA for the investigational single tablet... Dec 08 2016
Gilead Submits New Drug Application to U.S. Food and Drug Administration for the Investigational... Dec 08 2016
Gilead Submits New Drug Application to U.S. Food and Drug Administration for the Investigational... Dec 08 2016
Gilead's CEO Apologetic About Sovaldi's $1,000 Per Pill Price Tag Dec 08 2016
Trump's corporate tax holiday could spur pharma M&A Dec 06 2016
Dealtalk: Trump's corporate tax holiday could spur pharma M&A Dec 06 2016
Dealtalk: Trump's corporate tax holiday could spur pharma M&A Dec 06 2016
Gilead Sciences: Nothing to See Here…Except the Need for M&A Dec 05 2016
5 Healthcare Stocks Billionaires Love The Most Dec 04 2016
[$$] NHS to launch three-year anti-HIV PrEP trial Dec 04 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)